Incorporated in 2010, JFL Life Sciences Limited is engaged in the business of manufacturing of pharmaceutical products. The company’s product portfolio consists of Dry powder injections (B-Lactam), Tablets & Capsules (B-Lactam) solid oral dosage form and Tablet and capsules (general) Solid Oral Dosage Form and Oral rehydration solutions (ORS).
The company’s sales strategy is to sell the products in bulk to pharmaceutical marketers and traders who in turn provide the channel for sales to customers. JFL Life Sciences Limited has a market presence in PAN India and JFL’s products are supplied to 10 developed and developing countries throughout the World.
JFL Life Sciences Limited exports products to African, Middle Eastern, and CIS countries, mainly through merchant exporters. The company is registered with the MOH of Kenya, Nigeria, Yemen, Cambodia & Myanmar for manufacturing a particular product. Few of our products are also registered with Ukraine, Uzbekistan, and Kazakhstan (CIS countries) through merchants.
Competitive Strength :
- Product registration
- Quality assurance
- Quality & Brand strength
Objectives of the Issue:
The Company proposes to utilize the funds which are being raised through this Issue (“Net Proceeds”) towards the following objects:
- Repayment of secured and unsecured loans.
- Funding the working capital requirements of the company.
- General Corporate Purposes.
SMART IPO using UPI, you can now apply online
For Existing Clients : https://gudwil.in/IPO
Open an account : https://gudwil.in/smart
Further any clarification, feel free to contact your Branch / Relationship Manager.
For all your investment needs feel free to reach us. Give us a missed call at 90037 90027. For Support: 044-40329999